These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14653617)

  • 1. Evaluation of an MRI-based protocol for cell implantation in four patients with Huntington's disease.
    Watts C; Donovan T; Gillard JH; Antoun NM; Burnstein R; Menon DK; Carpenter TA; Fryer T; Thomas DG; Pickard JD
    Cell Transplant; 2003; 12(7):697-704. PubMed ID: 14653617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards a protocol for the preparation and delivery of striatal tissue for clinical trials of transplantation in Huntington's disease.
    Watts C; Dunnett SB
    Cell Transplant; 2000; 9(2):223-34. PubMed ID: 10811395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal grafts in a rat model of Huntington's disease: time course comparison of MRI and histology.
    Guzman R; Meyer M; Lövblad KO; Ozdoba C; Schroth G; Seiler RW; Widmer HR
    Exp Neurol; 1999 Mar; 156(1):180-90. PubMed ID: 10192789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The morphology, integration, and functional efficacy of striatal grafts differ between cell suspensions and tissue pieces.
    Watts C; Brasted PJ; Dunnett SB
    Cell Transplant; 2000; 9(3):395-407. PubMed ID: 10972338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staging and preparation of human fetal striatal tissue for neural transplantation in Huntington's disease.
    Rosser AE; Barker RA; Armstrong RJ; Elneil S; Jain M; Hurelbrink CB; Prentice A; Carne C; Thornton S; Hutchinson H; Dunnett SB
    Cell Transplant; 2003; 12(7):679-86. PubMed ID: 14653615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term hibernation of human fetal striatal tissue does not adversely affect its differentiation in vitro or graft survival: implications for clinical trials in Huntington's disease.
    Hurelbrink CB; Tyers P; Armstrong RJ; Dunnett SB; Barker RA; Rosser AE
    Cell Transplant; 2003; 12(7):687-95. PubMed ID: 14653616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating fetal neural transplants into a therapeutic strategy: the example of Huntington's disease.
    Peschanski M; Bachoud-Lévi AC; Hantraye P
    Brain; 2004 Jun; 127(Pt 6):1219-28. PubMed ID: 15047588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic technique and pathophysiological mechanisms of neurotransplantation in Huntington's chorea.
    Sramka M; Rattaj M; Molina H; Vojtassák J; Belan V; Ruzický E
    Stereotact Funct Neurosurg; 1992; 58(1-4):79-83. PubMed ID: 1439353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor-containing cortical and intraventricular glioneuronal nodules in Huntington's disease brain decades after fetal cell transplantation.
    Pinarbasi ES; Liu EA; Yu Z; Kopyov O; Brown NA; Dayalu P; Lieberman AP
    Acta Neuropathol; 2021 Jun; 141(6):979-981. PubMed ID: 33683397
    [No Abstract]   [Full Text] [Related]  

  • 10. Stereotactic MR imaging for planning neural transplantation: a reliable technique at 3 Tesla?
    Donovan T; Fryer TD; Peña A; Watts C; Carpenter TA; Pickard JD
    Br J Neurosurg; 2003 Oct; 17(5):443-9. PubMed ID: 14635750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of human striatal anlagen after transplantation in a patient with Huntington's disease.
    Gallina P; Paganini M; Lombardini L; Saccardi R; Marini M; De Cristofaro MT; Pinzani P; Salvianti F; Crescioli C; Di Rita A; Bucciantini S; Mechi C; Sarchielli E; Moretti M; Piacentini S; Gritti G; Bosi A; Sorbi S; Orlandini G; Vannelli GB; Di Lorenzo N
    Exp Neurol; 2008 Sep; 213(1):241-4. PubMed ID: 18601923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic planning software for human neurotransplantation: suitability in 22 surgical cases of Huntington's disease.
    Lopez WO; Nikkhah G; Schültke E; Furlanetti L; Trippel M
    Restor Neurol Neurosci; 2014; 32(2):259-68. PubMed ID: 24164802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study.
    Bachoud-Lévi AC; Gaura V; Brugières P; Lefaucheur JP; Boissé MF; Maison P; Baudic S; Ribeiro MJ; Bourdet C; Remy P; Cesaro P; Hantraye P; Peschanski M
    Lancet Neurol; 2006 Apr; 5(4):303-9. PubMed ID: 16545746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human striatal neuroblasts develop and build a striatal-like structure into the brain of Huntington's disease patients after transplantation.
    Gallina P; Paganini M; Lombardini L; Mascalchi M; Porfirio B; Gadda D; Marini M; Pinzani P; Salvianti F; Crescioli C; Bucciantini S; Mechi C; Sarchielli E; Romoli AM; Bertini E; Urbani S; Bartolozzi B; De Cristofaro MT; Piacentini S; Saccardi R; Pupi A; Vannelli GB; Di Lorenzo N
    Exp Neurol; 2010 Mar; 222(1):30-41. PubMed ID: 20026043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of the human striatum: implications for fetal striatal transplantation in the treatment of Huntington's disease.
    Freeman TB; Sanberg PR; Isacson O
    Cell Transplant; 1995; 4(6):539-45. PubMed ID: 8714776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal allografts in patients with Huntington's disease: impact of diminished astrocytes and vascularization on graft viability.
    Cisbani G; Freeman TB; Soulet D; Saint-Pierre M; Gagnon D; Parent M; Hauser RA; Barker RA; Cicchetti F
    Brain; 2013 Feb; 136(Pt 2):433-43. PubMed ID: 23378216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease.
    Barker RA; Mason SL; Harrower TP; Swain RA; Ho AK; Sahakian BJ; Mathur R; Elneil S; Thornton S; Hurrelbrink C; Armstrong RJ; Tyers P; Smith E; Carpenter A; Piccini P; Tai YF; Brooks DJ; Pavese N; Watts C; Pickard JD; Rosser AE; Dunnett SB;
    J Neurol Neurosurg Psychiatry; 2013 Jun; 84(6):657-65. PubMed ID: 23345280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell therapy for Huntington's disease, the next step forward.
    Peschanski M; Dunnett SB
    Lancet Neurol; 2002 Jun; 1(2):81. PubMed ID: 12849508
    [No Abstract]   [Full Text] [Related]  

  • 19. Human fetal striatal transplantation in huntington's disease: a refinement of the stereotactic procedure.
    Gallina P; Paganini M; Di Rita A; Lombardini L; Moretti M; Vannelli GB; Di Lorenzo N
    Stereotact Funct Neurosurg; 2008; 86(5):308-13. PubMed ID: 18791332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hibernated human fetal striatal tissue: successful transplantation in a rat model of Huntington's disease.
    Hurelbrink CB; Armstrong RJ; Barker RA; Dunnett SB; Rosser AE
    Cell Transplant; 2000; 9(6):743-9. PubMed ID: 11202561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.